Phunware Inc (NASDAQ:PHUN) told investors that its Board of Directors has authorized a stock repurchase plan under which the company may buy back up to $5 million of its outstanding common stock.
Russ Buyse, CEO of the enterprise cloud platform for mobile, said in a statement: “We believe repurchasing our common stock is an attractive use of capital, given recent market prices.”
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) and semiconductor solutions company OMNIVISION have announced the successful integration of Seeing Machines' in-cabin monitoring system technology (ICMS) with OMNIVISION’s OAX4600 system-on-chip (SoC) integrated circuit platform.
Optimized by Seeing Machines' Occula neural processing unit (NPU), the OMNIVISION OAX4600 will provide automakers with a new, powerful, and cost-effective solution to meet and exceed the regulatory requirements associated with the European Commission's General Safety Regulation as well as Europe's New Car Assessment Program (Euro NCAP) protocols.
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said it sees significant expansion opportunities for its pharma services operation, which has the potential to bring in near-term revenues in the large cancer drug trials market.
The company's liquid biopsy system, known as Parsortix, is designed to detect circulating tumour cells and has gained clearance from the US Food and Drug Administration (FDA), allowing ANGLE to work with major drug companies on projects.
Lake Resources NL (ASX:LKE, OTCQB:LLKKF) continues to strengthen its executive team with the appointment of Mark Anning as head of Legal, Australia and as company secretary.
This appointment will be effective on January 9, 2023, with Peter Nielsen stepping down as company secretary on that date but will remain the company's chief financial officer.
Alkane Resources Ltd (ASX:ALK) has upgraded its FY 2023 guidance for the Tomingley Gold Operations in Central West New South Wales to between 62,000 and 70,000 ounces of gold at an all-in sustaining costs (AISC) of $1,550 to $1,800 per ounce for this year.
This is after Tomingley exceeded forecast in the December quarter to produce 18,301 ounces of gold, bringing the six months to December 31, 2022 production to 37,790 ounces.
Co-Diagnostics Inc (NASDAQ:CODX) will host a booth this week at the 2023 Consumer Electronics Show (CES) this year from January 5-8 in Las Vegas, Nevada. The company will be exhibiting its upcoming Co-Dx PCR at-home and point-of-care platform, currently in the final stages of preparation for clinical evaluations prior to submission to the U.S. Food and Drug Administration for regulatory authorization. Attendees interested in learning more about the company and its products are invited to visit Booth #8063 in the North Hall of the Las Vegas Convention Center.
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced today that the U.S. Food & Drug Administration has granted the company’s Type C meeting request to obtain agreement on the revised protocol endpoints for its Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine, an oral drug with anti-inflammatory and antiviral properties, in patients with mild to moderate COVID-19. The goal date for the FDA to provide its written responses is March 7, 2023.
G2 Energy Corp (CSE:GTOO, OTC:GTGEF) announced that effective January 4, 2023, the management cease trade order issued by the company's principal regulator, the British Columbia Securities Commission on October 31, 2022 under National Policy 12-203 Management Cease Trade Orders has been revoked, as the company has now successfully completed all filings related to its annual and interim financial statements.
AIM ImmunoTech Inc (NYSE:AIM) announced its CEO Thomas Equels will present at the Virtual Investor 2023 Companies to Watch Event on Wednesday, January 18, 2023, at 11:00 AM ET. A live video webcast of the presentation will be available on the Events & Presentations page of the company’s website (aimimmuno.com). A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.
Xigem Technologies (CSE:XIGM, OTCQB:XIGMF) announced that it has granted 1,820,000 incentive stock options under its Stock Option Plan. Each option entitles the holder to purchase one common share of the company at an exercise price of $0.09 for a period of five years from the date of grant and will vest immediately. The options include 490,000 options for officers of the company, 750,000 options for directors of the company, 475,000 options for consultants to the company and 105,000 options for members of the company's Advisory Board. The options were granted on January 5, 2023, by Xigem's board of directors.
Zoglo's Incredible Food Corp. (CSE:ZOG)'s CEO and chief operations officer Jim Delsnyder has resigned, effective December 30, 2022, according to a statement. The plant-based food company will undergo a search for a new chief executive with an emphasis on leading US expansion. Meanwhile, Jordan Ender has been appointed as a director of the company. Ender has more 15 years of experience in the food retail, broker and distribution industry, and he is a VP of Grey Jay Sales & Distribution Ltd. Additionally, Zoglo said it will not proceed with the grant of 4,351,209 stock options, which had been previously announced on December 22.
Xeris Biopharma Holdings (NASDAQ:XERS) announced that CEO Paul Edick will present an overview of the Company at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 pm Pacific Time. To access the presentation, please visit “Events” on the investor relations page of the company’s website at www.xerispharma.com.
Rio2 Limited (TSX-V:RIO, OTCQX:RIOFF) announced that the company has entered into shares for services agreements with certain directors, employees, and consultants whereby they will receive all or a portion of their director fees, wages, or consultancy fees for the period from January 1, 2023 to December 31, 2023 in common shares of the company. The total value of the security based compensation that the company intends to issue is up to $750,000. Alex Black, Klaus Zeitler, Andrew Cox, Ram Ramachandran, Sidney Robinson, Drago Kisic and Albrecht Schneider are currently directors of the company.